LIVE SESSION BRIEF Medical Devices $44.80B Cap Quant: EXTENDED

Edwards Lifesciences Corp (EW) — Live Session & Technical Brief

Updated Nov 16, 2026 2:07 PM ET · Prev Close $107.15

Pro Workspace
Last Session Price
$106.66 -0.46%
-$0.50 vs $107.15 prior close
Intraday Range
$104.94 – $108.00
Open $107.00
Relative Volume
0.37x Avg
1,724,988 sh
52-Week Range
$74.66 – $108.00
Benchmark Alpha
+1.43% vs SPY
+1.96% vs QQQ
20-Session Trend +20.8%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.46%) in Medical Devices

Edwards Lifesciences Corp (EW) is trading within a tight intraday band at $106.66 (-0.46%, 0.37x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, EW is outperforming the S&P 500 by +1.43%. 14-day RSI stands at 79.4, keeping momentum in a overbought regime.

NEWS 70% Weight
Is There Any Reason To Invest In Edwards Lifesciences Stock?

For questions about this article or underlying research, email help trefis.com.

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($106.66) holds above both 20-day ($97.03) and 50-day ($90.77) moving averages.

Volume Confirmation
LOW VOLUME (0.37x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

EW outperforming the S&P 500 by +1.43%
EW Session
-0.46%
$106.66
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: +1.43% Alpha vs QQQ: +1.96% Alpha vs XLV: -0.08%

Recent EW Catalyst Headlines

Verified Wire
Edwards Lifesciences Q3 Earnings Call Highlights

Edwards Lifesciences NYSE Ew raised its 2026 sales and earnings guidance after third-quarter results exceeded management s expectations, with growth across its heart-valve businesses and regions. The medical device maker

Yahoo Finance · Nov 07, 2026

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$104.08
Short-term support band
Upper Bound
$109.24
Short-term resistance band
Key Inflection Level
$97.03 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $97.03 (20-day SMA support) for directional breakout confirmation.

Technical Regime (EW)

BULLISH MA TREND
RSI (14)
79.4
Overbought
20-Day SMA
$97.03
Above 20d
50-Day SMA
$90.77
Above 50d
MACD Signal
Bullish
MACD 4.88
ADX (14)
37.0
Strong trend
10d Momentum
+13.71
Strong upward 10-day rate of change

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.1
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Edwards Lifesciences announced positive results from the Progress trial of its TAVR system, showing superiority over clinical surveillance for moderate aortic stenosis patients with at-risk features.

Reddit communities: 1 comment (Neutral)

About Edwards Lifesciences Corp

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives …

Sector
Healthcare
Market Cap
$44.80B
Forward P/E
29.9x
Employees
15,800

Get Instant EW Catalyst Alerts

Receive an email alert when EW triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

EW Session & Catalyst FAQ

Why is EW stock trading near flat today?

Edwards Lifesciences Corp (EW) is trading within a tight intraday band at $106.66 (-0.46%, 0.37x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, EW is outperforming the S&P 500 by +1.43%. 14-day RSI stands at 79.4, keeping momentum in a overbought regime.

Is EW stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.37x relative volume (low participation). Our multi-factor model currently rates EW as EXTENDED. Review full valuation, quality, and timing signals on the EW Buy or Sell Decision Brief →

What is EW's intrinsic value and expected trading range?

At $106.66, EW's modeled 1-to-3 session range is $104.08 – $109.24, with a key inflection level at $97.03 (20-day SMA support). Compare current price against multi-year cash flow projections in the EW Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for EW?

RSI at 79.4 indicates overbought momentum — elevated pullback risk. EW trades at $106.66 relative to its 20-day SMA ($97.03) and 50-day SMA ($90.77), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs